deltatrials
Completed OBSERVATIONAL NCT04175626

Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions (BIOFLOW-VII)

BIOTRONIK - A Prospective Multicenter Study to Confirm the SaFety and Effectiveness of the Orsiro SiroLimus Eluting Coronary Stent System in the Treatment Of Subjects With up to Three De Novo or Restenotic Coronary Artery Lesions - VII

Sponsor: Biotronik, Inc.

Interventions Orsiro DES
Updated 23 times since 2019 Last updated: Feb 8, 2026 Started: Jan 24, 2020 Primary completion: Jan 12, 2022 Completion: Jan 8, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Acute Coronary Syndrome and Angina Pectoris, this trial is completed. The trial is conducted by Biotronik, Inc. and has accumulated 23 data snapshots since 2020. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Dec 2019 – ~Feb 2020 · 2 months · monthly snapshot~Feb 2020 – ~Mar 2020 · 29 days · monthly snapshot~Mar 2020 – ~Apr 2020 · 31 days · monthly snapshot~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Jun 2020 · 31 days · monthly snapshot~Jun 2020 – ~Jul 2020 · 30 days · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshot~Sep 2020 – ~Oct 2020 · 30 days · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~May 2021 · 2 months · monthly snapshot~May 2021 – ~Apr 2022 · 11 months · monthly snapshot~Apr 2022 – ~May 2024 · 25 months · monthly snapshot~May 2024 – ~Jun 2024 · 31 days · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~May 2025 · 8 months · monthly snapshot~May 2025 – ~Sep 2025 · 4 months · monthly snapshot~Sep 2025 – ~Feb 2026 · 5 months · monthly snapshot~Feb 2026 – present · 6 months · monthly snapshot

Change History

23 versions recorded
  1. Feb 2026 — Present [monthly]

    Completed

    Status: Active Not RecruitingCompleted

  2. Sep 2025 — Feb 2026 [monthly]

    Active Not Recruiting

  3. May 2025 — Sep 2025 [monthly]

    Active Not Recruiting

  4. Sep 2024 — May 2025 [monthly]

    Active Not Recruiting

  5. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting

Show 18 earlier versions
  1. Jun 2024 — Jul 2024 [monthly]

    Active Not Recruiting

  2. May 2024 — Jun 2024 [monthly]

    Active Not Recruiting

  3. Apr 2022 — May 2024 [monthly]

    Active Not Recruiting

  4. May 2021 — Apr 2022 [monthly]

    Active Not Recruiting

  5. Mar 2021 — May 2021 [monthly]

    Active Not Recruiting

  6. Jan 2021 — Mar 2021 [monthly]

    Active Not Recruiting

    Status: RecruitingActive Not Recruiting

  7. Dec 2020 — Jan 2021 [monthly]

    Recruiting

  8. Nov 2020 — Dec 2020 [monthly]

    Recruiting

  9. Oct 2020 — Nov 2020 [monthly]

    Recruiting

  10. Sep 2020 — Oct 2020 [monthly]

    Recruiting

  11. Aug 2020 — Sep 2020 [monthly]

    Recruiting

  12. Jul 2020 — Aug 2020 [monthly]

    Recruiting

  13. Jun 2020 — Jul 2020 [monthly]

    Recruiting

  14. May 2020 — Jun 2020 [monthly]

    Recruiting

  15. Apr 2020 — May 2020 [monthly]

    Recruiting

  16. Mar 2020 — Apr 2020 [monthly]

    Recruiting

  17. Feb 2020 — Mar 2020 [monthly]

    Recruiting

    Status: Not Yet RecruitingRecruiting

  18. Dec 2019 — Feb 2020 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Biotronik, Inc.
Data source: Biotronik, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .